Smoking is an Independent Marker of Poor Prognosis in Cutaneous Melanoma

Previous studies have suggested that persistent tobacco smoking impairs survival in cutaneous melanoma, but the effects of smoking and other prognostic factors have not been described in detail. This study examined the association of smoking (persistent, former, or never) with melanoma-specific (MSS...

Full description

Saved in:
Bibliographic Details
Main Authors: Kalle Mattila (Author), Helmi Vihinen (Author), Antti Karlsson (Author), Heikki Minn (Author), Pia Vihinen (Author), Eetu Heervä (Author)
Format: Book
Published: Medical Journals Sweden, 2023-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8a6ed2ba966c48ec87a292d510f66a59
042 |a dc 
100 1 0 |a Kalle Mattila  |e author 
700 1 0 |a Helmi Vihinen  |e author 
700 1 0 |a Antti Karlsson  |e author 
700 1 0 |a Heikki Minn  |e author 
700 1 0 |a Pia Vihinen  |e author 
700 1 0 |a Eetu Heervä  |e author 
245 0 0 |a Smoking is an Independent Marker of Poor Prognosis in Cutaneous Melanoma 
260 |b Medical Journals Sweden,   |c 2023-02-01T00:00:00Z. 
500 |a 10.2340/actadv.v103.3209 
500 |a 0001-5555 
500 |a 1651-2057 
520 |a Previous studies have suggested that persistent tobacco smoking impairs survival in cutaneous melanoma, but the effects of smoking and other prognostic factors have not been described in detail. This study examined the association of smoking (persistent, former, or never) with melanoma-specific (MSS) and overall survival (OS) in patients with cutaneous melanoma treated in Southwest Finland during 2005 to 2019. Clinical characteristics were obtained from electronic health records for 1,980 patients. Smoking status was available for 1,359 patients. Patients were restaged according to the 8th edition of the tumour-node-metastasis (TNM) classification. Smoking remained an independent prognostic factor for inferior melanoma-specific survival regardless of age, sex, stage, and comorbidities. The hazard ratio of death from melanoma was 1.81 (1.27−2.58, p = 0.001) in persistent and 1.75 (1.28−2.40, p = 0.001) in former smokers compared with never smokers. In 351 stage IV patients, smoking was associated with increased melanoma-specific and overall mortality: median MSS 10.4 (6.5−14.3), 14.6 (9.1−20.1), and 14.9 (11.4−18.4) months, p = 0.01 and median OS 10.4 (6.5−14.3), 13.9 (8.6−19.2), and 14.9 (11.7−18.1) months, p = 0.01 in persistent, former, and never smokers, respectively. In conclusion, since smoking represents an independent modifiable poor prognostic factor in patients with cutaneous melanoma, smoking habits should be proactively asked about by healthcare professionals, in order to support smoking cessation. 
546 |a EN 
690 |a cigarette 
690 |a melanoma 
690 |a metastasis 
690 |a skin cancer 
690 |a smoking 
690 |a survival 
690 |a Dermatology 
690 |a RL1-803 
655 7 |a article  |2 local 
786 0 |n Acta Dermato-Venereologica, Vol 103 (2023) 
787 0 |n https://medicaljournalssweden.se/actadv/article/view/3209 
787 0 |n https://doaj.org/toc/0001-5555 
787 0 |n https://doaj.org/toc/1651-2057 
856 4 1 |u https://doaj.org/article/8a6ed2ba966c48ec87a292d510f66a59  |z Connect to this object online.